Tilray’s Highs and Lows
Canadian medical cannabis company Tilray’s stock surged by over 77 percent in the first three trading days of…
AMERICAS
Mexico’s Healthcare System: Perspectives from the Pharma Sector
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion…
“Restricting Drug Patent Settlements is Bad for US Patients”
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US…
How California is Setting the Standard for Gender Diversity
Robin Toft is the Author of WE CAN™, the Executive Woman’s Guide to Career Advancement and founder and CEO of…
“Canada Needs to do Better in Supporting Innovative Biopharma”
Brian Hilberdink, President of Novo Nordisk Canada, calls for the Canadian government to encourage and invest in…
Generics: Pioneered by Women
As part of Women’s History Month, Chip Davis, president and CEO of the Association for Accessible Medicines…
Orphan Drugs in the USA: A Snapshot
80 orphan drugs (those drugs intended to treat diseases so rare that sponsors are reluctant to develop them under…
Top 20 Pharma Companies in Brazil Ranking 2017
The Top 20 pharma companies in Brazil for 2017, combining the data for both the retail and non-retail markets.…
How do we Encourage Patients to Continue Taking their Medicines?
David Peña Castillo, president and founder of the Mexican Federation of Rare Diseases (FEMEXER), addresses the…
